Abstract
Whatever the aetiology and whatever the severity, the active management of respiratory failure habitually results in the administration of supplemental oxygen therapy. This review re-examines aspects of the optimization of such therapy. The oft-cited and well described risks of oxygen toxicity are revisited. Although no universal absolutes can be stipulated, the safe use of oxygen therapy is explored with particular reference to optimal oxygen targets. Specific attention is directed to the balance between the tolerable lower limits of systemic oxygenation and the putatively safe limits for titration of supplemental inspired oxygen fraction. Additional consideration is given to the emerging concept of permissive hypoxaemia. The attractiveness of this notion, and its potential role when the adverse effects of pursuing increased oxygenation combine to outweigh any benefit, has been enhanced by recent experiences with severe hypoxic respiratory failure arising from pandemic influenza viruses. Significant shortcomings remain in the existing definitions and descriptors of dysoxia, as well as the available technology for monitoring oxygenation. In clinical practice, oxygen displays a relatively narrow therapeutic index, and requires a careful balance of its benefits and risks. A detailed understanding of this ubiquitous therapy is obligatory in the optimal care of the critically ill.
Keywords: Oxygen, oxygen inhalational therapy, respiratory failure, blood gas, analysis
Current Respiratory Medicine Reviews
Title: Optimal Oxygen Therapy in the Critically Ill Patient with Respiratory Failure
Volume: 6 Issue: 4
Author(s): Gerard McHugh and Ross Freebairn
Affiliation:
Keywords: Oxygen, oxygen inhalational therapy, respiratory failure, blood gas, analysis
Abstract: Whatever the aetiology and whatever the severity, the active management of respiratory failure habitually results in the administration of supplemental oxygen therapy. This review re-examines aspects of the optimization of such therapy. The oft-cited and well described risks of oxygen toxicity are revisited. Although no universal absolutes can be stipulated, the safe use of oxygen therapy is explored with particular reference to optimal oxygen targets. Specific attention is directed to the balance between the tolerable lower limits of systemic oxygenation and the putatively safe limits for titration of supplemental inspired oxygen fraction. Additional consideration is given to the emerging concept of permissive hypoxaemia. The attractiveness of this notion, and its potential role when the adverse effects of pursuing increased oxygenation combine to outweigh any benefit, has been enhanced by recent experiences with severe hypoxic respiratory failure arising from pandemic influenza viruses. Significant shortcomings remain in the existing definitions and descriptors of dysoxia, as well as the available technology for monitoring oxygenation. In clinical practice, oxygen displays a relatively narrow therapeutic index, and requires a careful balance of its benefits and risks. A detailed understanding of this ubiquitous therapy is obligatory in the optimal care of the critically ill.
Export Options
About this article
Cite this article as:
McHugh Gerard and Freebairn Ross, Optimal Oxygen Therapy in the Critically Ill Patient with Respiratory Failure, Current Respiratory Medicine Reviews 2010; 6 (4) . https://dx.doi.org/10.2174/157339810793563695
DOI https://dx.doi.org/10.2174/157339810793563695 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Current Pharmaceutical Design Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants
Infectious Disorders - Drug Targets Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
Endocrine, Metabolic & Immune Disorders - Drug Targets The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes
Current Vascular Pharmacology Chemical Constituents and Biological Significance of the Genus Ilex (Aquifoliaceae)
The Natural Products Journal Pneumonia in the Burn Patient
Current Respiratory Medicine Reviews Isolation and Boactivities of Furfuran Type Lignan Compounds from Edible Plants
Recent Patents on Food, Nutrition & Agriculture Recreational Drug Misuse and Stroke
Current Drug Abuse Reviews N-Acetylcysteine for the Treatment of Obsessive-Compulsive Disorder
Current Psychiatry Reviews Enhanced Anticancer Activity and Apoptosis Effect of Bioactive Compound Quercetin Extracted from <i>Ocimum sanctum</i> Leaves
Current Nanomedicine The Role of Liver Biopsy to Assess Alcoholic Liver Disease
Reviews on Recent Clinical Trials Opioids and Mechanical Ventilation
Current Drug Targets Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype
Current Gene Therapy Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Nitric Oxide Signaling and the Cross Talk with Prostanoids Pathways in Vascular System
Medicinal Chemistry In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Current Neuropharmacology Turnover Studies on Cardiac Natriuretic Peptides: Methodological,Pathophysiological and Therapeutical Considerations.
Current Drug Metabolism The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration
Current Molecular Medicine Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety